Basu, A.P., Low, K., Ratnaike, T., & Rowitch, D. (2024). Genetic investigations in cerebral palsy. Developmental Medicine & Child Neurology, 1–9. https://doi.org/10.1111/dmcn.16080
Bawor, M., Dennis, B. B., Anglin, R., Steiner, M., Thabane, L., & Samaan, Z. (2014). Sex differences in outcomes of methadone maintenance treatment for opioid addiction: A systematic review protocol. Systematic Reviews, 3, 45. https://doi.org/10.1186/2046-4053-3-45
Article PubMed PubMed Central Google Scholar
Bulot, V., Ramond, F., Mauguière, F., & Mazzola, L. (2022). Startle disease: An overlooked symptom of CTNNB1-related neurodevelopmental disorder with spastic diplegia and visual defects. Neurology Genetics, 8(6), e200039. https://doi.org/10.1212/NXG.0000000000200039
Article PubMed PubMed Central Google Scholar
Caracci, M.O., Avila, M.E., Espinoza-Cavieres, F.A., López, H.R., Ugarte, G.D., & De Ferrari, G.V. (2021). Wnt/β-catenin-dependent transcription in autism spectrum disorders. Frontiers in Molecular Neurosciences, 14. https://doi.org/10.3389/fnmol.2021.764756
Chaves, L. D., Caravalho, L. M. L., Tolezano, G. C., Pires, S. F., Costa, S. S., de Scliar, M. O., Giuliani, L. R., Bertola, D. R., Santos-Rebouças, C. B., Seo, G. H., Otto, P. A., Rosenberg, C., Vianna-Morgante, A. M., & Krepischi, A. C. V. (2023). Skewed X-chromosome inactivation in women with idiopathic intellectual disability is indicative of pathogenic variants. Molecular Neurobiology, 60(7), 3758–3769. https://doi.org/10.1007/s12035-023-03311-0
Article CAS PubMed Google Scholar
Cordeiro, D., Bullivant, G., Siriwardena, K., Evans, A., Kobayashi, J., Cohn, R. D., & Mercimek-Andrews, S. (2018). Genetic landscape of pediatric movement disorders and management implications. Neurology Genetics, 4(5), e265. https://doi.org/10.1212/NXG.0000000000000265
Article PubMed PubMed Central Google Scholar
Coussa, R. G., Zhao, Y., DeBenedictis, M. J., Babiuch, A., Sears, J., & Traboulsi, E. I. (2020). Novel mutation in CTNNB1 causes familial exudative vitreoretinopathy (FEVR) and microcephaly: Case report and review of the literature. Ophthalmic Genetics, 41(1), 63–68. https://doi.org/10.1080/13816810.2020.1723118
Article CAS PubMed Google Scholar
Dashti, S., Salehpour, S., Ghasemi, M. R., Sadeghi, H., Rostami, M., Hashemi-Gorji, F., Mirfakhraie, R., Yassaee, V. R., & Miryounesi, M. (2022). Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability. Neurological Sciences, 43(4), 2859–2863. https://doi.org/10.1007/s10072-022-05904-4
de Ligt, J., Willemsen, M. H., van Bon, B. W. M., Kleefstra, T., Yntema, H. G., Kroes, T., Vulto-van Silfhout, A. T., Koolen, D. A., de Vries, P., Gilissen, C., del Rosario, M., Hoischen, A., Scheffer, H., de Vries, B. B. A., Brunner, H. G., Veltman, J. A., & Vissers, L. E. L. M. (2012). Diagnostic exome sequencing in persons with severe intellectual disability. New England Journal of Medicine, 367(20), 1921–1929. https://doi.org/10.1056/NEJMoa1206524
Article CAS PubMed Google Scholar
Dixon, M. W., Stem, M. S., Schuette, J. L., Keegan, C. E., & Besirli, C. G. (2016). CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype. Ophthalmic Genetics, 37(4), 468–470. https://doi.org/10.3109/13816810.2015.1120318
Dubruc, E., Putoux, A., Labalme, A., Rougeot, C., Sanlaville, D., & Edery, P. (2014). A new intellectual disability syndrome caused by CTNNB1 haploinsufficiency. American Journal of Medical Genetics Part A, 146A(6), 1571–1575. https://doi.org/10.1002/ajmg.a.36484
Gonzalez-Mantilla, P. J., Hu, Y., Myers, S. M., Finucane, B. M., Ledbetter, D. H., Martin, C. L., & Moreno-De-Luca, A. (2023). Diagnostic yield of exome sequencing in cerebral palsy and implications for genetic testing guidelines: A systematic review and meta-analysis. JAMA Pediatrics, 177(5), 472–478. https://doi.org/10.1001/jamapediatrics.2023.0008
Article PubMed PubMed Central Google Scholar
Ho, S.K.L., Tsang, M.H.Y., Lee, M., Cheng, S.S.W., Luk, H.L., Lo, I.F.M., & Chung, B.H.Y. (2022). CTNNB1 neurodevelopmental disorder. Gene Reviews [Internet]. University of Washington.
Ho, S., Tsang, M. H., Fung, J. L., Huang, H., Chow, C. B., Cheng, S. S., Luk, H. M., Chung, B. H. Y., & Lo, I. F. (2022b). CTNNB1-related neurodevelopmental disorder in a Chinese population: A case series. American Journal of Medical Genetics. Part A, 188(1), 130–137. https://doi.org/10.1002/ajmg.a.62504
Article CAS PubMed Google Scholar
Ji, Y., Xia, Q., Zhang, H., Huo, H., Cao, X., Wang, W., & Gu, Q. (2023). Whole exome sequencing identified two novel truncation mutations in the CTNNB1 gene associated with neurodevelopmental disorder, language dysfunction, and microcephaly in Chinese children. Child Neurology Open, 10. https://doi.org/10.1177/2329048X231184184
Jin, S.C., Lewis, S.A., Bakhtiari, S., Zeng, X., Sierant, M.C., Shetty, S., Nordile, S.M., Elie, A., Corbett, M.A., Norton, B.Y., van Eyk, C.L., Haider, S., Guida, B.S., Magee, H., Liu, J., Pastore, S. Vincent, J.B., Brunstrom-Hernandez, J., Papavasileiou, A., … Kruer, M.C. (2020). Mutations disrupting neuritogenesis genes confer risk for cerebral palsy. Nature Genetics, 52(10), 1046-1056. https://doi.org/10.1038/s41588-020-0695-1
Kayumi, S., Pérez-Jurado, L.A., Palomares, M., Rangu, S., Sheppard, S.E., Chung, W.K., Kruer, M.C., Kharbanda, M., Amor, D.J., McGillivray, G., Cohen, J.S., García-Miñaúr, S., van Eyk, C.L., Harper, K., Jolly, L.A., Webber, D.L., Barnett, C.P., Santos-Simarro, F., Pacio-Míguez, M., … Corbett, M.A. (2022). Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants. Genetics in Medicine, 24 (11), 2351–2366. https://doi.org/10.1016/j.gim.2022.08.006
Ke, Z., & Chen, Y. (2020). Case report: A de novo CTNNB1 nonsense mutation associated with neurodevelopmental disorder, retinal detachment, polydactyly. Frontiers in Pediatrics, 8. https://doi.org/10.3389/fped.2020.575673
Keeratisitoj, O., Thawinchai, N., Siritaratiwat, W., Buntragulpoontawee, M., & Pratoomsoot, C. (2018). Prognostic predictors for ambulation in children with cerebral palsy: A systematic review and meta-analysis of observational studies. Disability and Rehabilitation, 40(2), 135–143. https://doi.org/10.1080/09638288.2016.1250119
Kharbanda, M., Pliz, D. T., Tomkins, S., Chandler, K., Saggar, A., Fryer, A., McKay, V., Louro, P., Smith, J. C., Burn, J., Kini, U., De Bruca, A., FitzPatrick, D. R., Kinning, E., Study DDD. (2017). Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals. European Journal Medical Genetics, 60(2), 130–135. https://doi.org/10.1016/j.ejmg.2016.11.008
Krupp, D. R., Barnard, R. A., Duffourd, Y., Evans, S. A., Mulqueen, R. M., Bernier, R., Rivière, J. B., Fombonne, E., & O’Roak, B. J. (2017). Exonic mosaic mutations contribute risk for autism spectrum disorder. The American Journal of Genetics, 101(3), 369–390. https://doi.org/10.1016/j.ajhg.2017.07.016
Kuechler, A., Willemsen, M.H., Albrecht, B., Bacino, C.A., Bartholomew, D.W, van Bokhoven, H., van den Boogaard, M.J.H., Bramswig, N., Büttner, C., Cremer, K., Czeschik, J.C., Engels, H., van Gassen, K., Graf, E., van Haelst, M., He, W., Hogue, J.S., Kempers, M., Koolen, D., ... Wieczorek, D. (2015). De novo mutations in beta-catenin (CTNNB1) appear to be a frequent cause of intellectual disability: Expanding the mutational and clinical spectrum. Human Genetics, 134 (1), 97–109. https://doi.org/10.1007/s00439-014-1498-1
Lee, S., Jang, S.S., Park, S., Yoon, J.G., Kim, S.Y., Lim, B.C., & Chae, J.H. (2022). The extended clinical and genetic spectrum of CTNNB1-related neurodevelopmental disorder. Frontiers in Pediatrics, 10. https://doi.org/10.3389/fped.2022.960450
Lee, J., Yoo, J., Lee, S., & Jang, D.H. (2023). CTNNB1-related neurodevelopmental disorder mimics cerebral palsy: Case report. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1201080
Li, N., Xu, Y., Li, G., Yu, T., Yao, R., Wang, X., & Wang, J. (2017). Exome sequencing identifies a de novo mutation of CTNNB1 gene in a patient mainly presented with retinal detachment, lens and vitreous opacities, microcephaly, and developmental delay: Case report and literature review. Medicine, 96(20), e6914. https://doi.org/10.1097/MD.0000000000006914
Article CAS PubMed PubMed Central Google Scholar
Maguschak, K. A., & Ressler, K. J. (2012). The dynamic role of beta-catenin in synaptic plasticity. Neuropharmacology, 62(1), 78–88. https://doi.org/10.1016/j.neuropharm.2011.08.032
Article CAS PubMed Google Scholar
Miroševič, S., Khandelwal, S., Sušjan, P., Žakelj, N., Gosar, D., Forstnerič, V., Lainšček, D., Jerala, R., & Osredkar, D. (2022). Correlation between phenotype and genotype in CTNNB1 syndrome: A systematic review of literature. Molecular Sciences, 23(20). https://doi.org/10.3390/ijms232012564
Moeinafshar, A., Tehrani-Fateh, S., Sadeghi, H., Karimzadeh, P., Mirfakhraie, R., Hashemi-Gorji, F., Larki, P., Miryounesi, M., & Ghasemi, M. R. (2023). Alopecia areata-like pattern of baldness: The most recent update and the expansion of novel phenotype and genotype in CTNNB1 gene. Neurological Sciences, 44(11), 4041–4048. https://doi.org/10.1007/s10072-023-06922-6
Nagy, N., Pál, M., Nagy, D., Bokor, B. A., Zimmermann, A., Gellén, B., Salamon, A., Sztriha, L., Klivényi, P., & Széll, M. (2024). A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder. BMC Pediatrics, 24(47), 1–6. https://doi.org/10.1186/s12887-023-04509-w
Onesimo, R., Sforza, E., Trevisan, V., Leoni, C., Giorgio, V., Rigante, D., Kuczynska, E.M., Proli, F., Agazzi, C., Limongelli, D., Digilio, M.C., Dentici, M.L., Macchiaiolo, M., Novelli, A., Bartuli, A., Sinibaldi, L., Tartaglia, M., & Zampino, G. (2023). From feeding challenges to oral-motor dyspraxia: A comprehensive description of 10 new cases with CTNNB1 syndrome. Genes, 14(10). https://doi.org/10.3390/genes14101843
Panagiotou, E. S., Sanjuro-Soriano, C., Poulter, J. A., Lord, E. C., Dzulova, D., Kondo, H., Hiyoshi, A., Chung, B. H., Chu, Y. W., Lai, C. H. Y., Tafoya, M. E., Karjosukarso, D., Collin, R. W. J., Topping, J., Downey, L. M., Ali, M., Inglehearn, C. F., & Toomes, C. (2017). Defects in the cell signaling mediator β-catenin cause the retinal vascular condition FEVR. The American Journal of Human Genetics, 100(6), 960–968. https://doi.org/10.1016/j.ajhg.2017.05.001
Article CAS PubMed Google Scholar
Paparella, A., Squeo, G. M., Di Venere, E., Cardea, E., Mazza, T., Castellana, S., Kerkhof, J., McConkey, H., Sadikovic, B., Sinibaldi, L., Digilio, M. C., & Merla, G. (2022). Genome-wide DNA methylation profiling and exome sequencing resolved a long-time misdiagnosed case. Journal of Human Genetics, 67(9), 547–551. https://doi.org/10.1038/s10038-022-01043-y
Article CAS PubMed Google Scholar
Percy, A. K., Lane, J., Annese, F., Warren, H., Skinner, S. A., & Neul, J. L. (2018). When Rett syndrome is due to genes other than MECP2. Translational Science of Rare Disease, 3(1), 49–53. https://doi.org/10.3233/TRD-180021
Pipo-Deveza, J., Fehlings, D., Chitayat, D., Yoon, G., Sroka, H., & Tein, I. (2018). Rationale for dopa-responsive CTNNB1/ β -catenin deficient dystonia. Movement Disorders, 33(4), 656–657. https://doi.org/10.1002/mds.27320
Prasad, M.K., Geoffroy, V., Vicaire, S., Jost, B., Dumas, M., Le Gras, S., Switala, M., Gasse, B., Laugel-Haushalter, V., Paschaki, M., Leheup, B., Droz, D., Dalstein, A., Loing, A. Grollemund, B., Muller-Bolla, M., Lopez-Cazaux, S., Minoux, M., Jung, S., … Bloch-Zupan, A. (2016). A targeted next-generation sequencing assay for the molecular diagnosis of genetic disorders with orodental involvement. Journal of Medical Genetics, 53(2), 98–110. https://doi.org/10.1136/jmedgenet-2015-103302
Retterer, K., Juusola, J., Cho, M.T., Vitazka, P., Millan, F., Gibellini, F., Vertino-Bell, A., Smaoui, N., Neidich, J., Monaghan, K.G., McKnight, D., Bai, R., Suchy, S., Friedman, B., Tahiliani, J., Pineda-Alvarez, D., Richard, G., Brandt, T., Haverfield, E., … Bale, S. (2016). Clinical application of whole-exome sequencing across clinical indications. Genetics in Medicine, 18(7), 696–704. https://doi.org/10.1136/jmedgenet-2015-103302
Rossetti, L. Z., Bekheirnia, M. R., Lewis, A. M., Mefford, H. C., Golden-Grant, K., Tarczy-Hornoch, K., Briere, L. C., Sweetser, D. A., Walker, M. A., Kravets, E., Stevenson, D. A., Bruenner, G., Sebastian, J., Knapo, J., Rosenfeld, J. A., Marcogliese, P. C., & Wrangler, M. F. (2020). Missense variants in CTNNB1 can be associated with vitreoretinopathy - Seven new cases of CTNNB1-associated neurodevelopmental disorder including a previously unreported retinal phenotype. Molecular Genetics & Genomic Medicine, 9(1), e1542. https://doi.org/10.1002/mgg3.1542
Comments (0)